Sana Biotechnology, Inc.SANANASDAQ
Loading
Operating Expenses Over TimeContracting
Percentile Rank43
3Y CAGR-4.3%
5Y CAGR+9.6%
Year-over-Year Change
Expenses from normal business operations (SG&A, R&D, etc.)
3Y CAGR
-4.3%/yr
vs +140.0%/yr prior
5Y CAGR
+9.6%/yr
Recent deceleration
Acceleration
-144.3pp
Decelerating
Percentile
P43
Within normal range
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| TTM | $238.69M | -12.5% |
| 2024 | $272.72M | -7.0% |
| 2023 | $293.14M | +7.5% |
| 2022 | $272.56M | -23.6% |
| 2021 | $356.91M | +136.4% |
| 2020 | $150.95M | +6.9% |
| 2019 | $141.15M | +1617.2% |
| 2018 | $8.22M | - |